Skip to main content

Table 3 Comparison of the characteristics from unrealistic pessimistic RP patients and unrealistic optimistic RP patients

From: Markers of disease severity and positive family history are associated to significant risk perception in rheumatoid arthritis, while compliance with therapy is not: a cross-sectional study in 415 Mexican outpatients

Characteristics

Unrealistic pessimistic RP patients, N = 32

Unrealistic optimistic RP patients, N = 24

p

Socio-demographic

 Female sex1

31 (96.9)

24 (100)

1

 Years of age

59.5 (49.6–64.6)

57.1 (43.3–61.7)

0.329

 Years of formal education

9 (6–15.8)

9 (6–12)

0.590

 Medium-low SE level1

29 (90.6)

24 (100)

0.252

RA-related

 Serum positive RF1

24 (75)

24 (100)

0.008

 Serum positive ACCP1

25 (78.1)

24 (100)

0.016

 Years of disease duration

13.5 (8.7–18)

18.5 (7.4–25)

0.329

 Rheumatoid nodes1

15 (46.9)

13 (54.2)

0.787

 RAPID-3

4.1 (1.4–12.6)

15.3 (14.1–18.7)

0.002

 High disease activity category1

6 (18.8)

19 (79.2)

≤ 0.0001

Patient-reported outcomes

 Pain-VAS

8 (3.3–14)

27.5 (7.6–36)

0.007

 Overall disease-VAS

7.5 (2–15)

32.5 (7.5–45.8)

0.001

 HAQ score

0.25 (0–1.1)

2 (1.4–2.5)

≤ 0.0001

 SF-36 score

77.2 (55.4–87.3)

42.5 (22.6–67)

≤ 0.0001

 Mental component score (SF-36)

71.9 (56.5–87.8)

48.1 (32–67)

0.002

 Physical component score (SF-36)

74 (48.9–84.6)

39.7 (17.4–53.3)

≤ 0.0001

Comorbidity

 Presence of comorbidity1

19 (59.4)

19 (79.2)

0.153

 Surgical joint replacement1

9 (28.1)

13 (54.2)

0.059

Treatment

 DMARDs/patient

1 (1–2)

2 (1–2)

0.165

 Corticosteroids use1

11 (34.4)

18 (75)

0.003

 Intensive treatment1

10 (31.3)

18 (75)

0.003

Compliance with treatment

 Adherence1

18 (56.3)

11 (45.8)

0.590

 Persistence1

19 (59.4)

111 (45.8)

0.418

 Concordance1

15 (46.9)

10 (41.7)

0.789

Miscellaneous

 Health Literacy1

24 (75)

22 (91.7)

0.162

 Adequate RA knowledge1 (based on CQ)

25 (44.6)

170 (47.4)

0.774

 RA family history1

18 (56.3)

10 (41.7)

0.418

Significant RP1

32 (100)

0

≤ 0.0001

Unfavorable medical criteria

5 (5–6)

7.5 (7–8)

≤ 0.0001

  1. Data are presented as the median and IQR unless otherwise indicated
  2. 1Number (%) of patients
  3. SE socioeconomic, RF rheumatoid factor, ACCP antibodies to cyclic citrullinated peptides, RAPID-3 Routine Assessment of Patients Index Score-3, VAS visual analogue scale, HAQ Health Assessment Questionnaire, SF-36 Short Form-36, DMARDs disease-modifying anti-rheumatic drugs, CQ Compliance Questionnaire, RA rheumatoid arthritis, RP risk perception